Last quarter (Q4 2022), Anatara Lifesciences Ltd's total revenue was $―, a decrease of ― from previous quarter. In Q4, Anatara Lifesciences Ltd's net income was $―. See Anatara Lifesciences Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ 663.40K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ 663.40K
Operating Expense	$ ―	$ 3.02M	$ 3.11M	$ 4.21M	$ 4.48M
Operating Income	$ ―	$ -3.02M	$ -3.11M	$ -4.21M	$ -3.82M
Net Non Operating Interest Income Expense	$ ―	$ 2.69K	$ 8.82K	$ 52.06K	$ 142.50K
Other Income Expense	$ ―	$ 487.24K	$ 1.11M	$ 789.21K	$ 807.97K
Pretax Income	$ ―	$ -2.53M	$ -2.00M	$ -3.36M	$ -2.87M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -2.53M	$ -2.00M	$ -3.36M	$ -2.87M
Basic EPS	$ ―	$ -0.03	$ -0.03	$ -0.07	$ -0.06
Diluted EPS	$ ―	$ -0.03	$ -0.03	$ -0.07	$ -0.06
Basic Average Shares	$ ―	$ 73.43M	$ 62.71M	$ 49.67M	$ 49.41M
Diluted Average Shares	$ ―	$ 73.43M	$ 62.71M	$ 49.67M	$ 49.41M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -2.53M	$ -2.00M	$ -3.36M	$ -2.87M
Normalized Income	$ ―	$ -2.53M	$ -2.00M	$ -3.36M	$ -2.87M
Interest Expense	$ ―	$ 3.32K	$ 300.00	$ ―	$ ―
EBIT	$ ―	$ -2.53M	$ -2.00M	$ -4.21M	$ -3.82M
EBITDA	$ ―	$ -2.50M	$ -1.99M	$ -4.19M	$ -3.80M

Currency in USD

Anatara Lifesciences Ltd Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing